217 related articles for article (PubMed ID: 16112595)
21. Tumour-induced osteomalacia: a rare cause of chronic pain and weakness.
Nasr JT; Tohme J; Collins MT; Drake MT; Hartley IR; Sfeir J; Dockery K; Taskin M
Pract Neurol; 2022 Dec; 22(6):528-531. PubMed ID: 35896375
[TBL] [Abstract][Full Text] [Related]
22. Hypophosphaturic mesenchymal tumor of the ethmoid associated with oncogenic osteomalacia.
Ungari C; Rocchi G; Rinna C; Agrillo A; Lattanzi A; Pagnoni M
J Craniofac Surg; 2004 May; 15(3):523-7. PubMed ID: 15111823
[TBL] [Abstract][Full Text] [Related]
23. Tubulointerstitial nephritis-induced hypophosphatemic osteomalacia in Sjögren's syndrome: a case report and review of the literature.
Geng Y; Zhao Y; Zhang Z
Clin Rheumatol; 2018 Jan; 37(1):257-263. PubMed ID: 28725949
[TBL] [Abstract][Full Text] [Related]
24. A unique case of adult hypophosphatemic osteomalacia.
Edelson GW; Shih MS; Parfitt AM
Bone; 1993; 14(5):707-10. PubMed ID: 8268043
[TBL] [Abstract][Full Text] [Related]
25. Tumor-induced osteomalacia associated with a maxillofacial tumor producing fibroblast growth factor 23: report of a case and review of the literature.
Mori Y; Ogasawara T; Motoi T; Shimizu Y; Chikazu D; Tamura K; Fukumoto S; Takato T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):e57-63. PubMed ID: 20219587
[TBL] [Abstract][Full Text] [Related]
26. Challenges in the management of tumor-induced osteomalacia (TIO).
Brandi ML; Clunie GPR; Houillier P; Jan de Beur SM; Minisola S; Oheim R; Seefried L
Bone; 2021 Nov; 152():116064. PubMed ID: 34147708
[TBL] [Abstract][Full Text] [Related]
27. A unique case of light chain (AL) amyloidosis masquerading as hypophosphatemic osteomalacia.
Malhotra R; Guleria P; Barwad A; Pramanik R; Tandon N
Osteoporos Int; 2021 Feb; 32(2):387-392. PubMed ID: 32910218
[TBL] [Abstract][Full Text] [Related]
28. Oncogenic osteomalacia secondary to nasal tumor with decreased urinary excretion of cAMP.
Kawai Y; Morimoto S; Sakaguchi K; Yoshino H; Yotsui T; Hirota S; Inohara H; Nakagawa T; Hattori K; Kubo T; Yang J; Fujiwara N; Ogihara T
J Bone Miner Metab; 2001; 19(1):61-4. PubMed ID: 11156476
[No Abstract] [Full Text] [Related]
29. Challenging case of tumour-induced osteomalacia.
Kumar P; Jadhav DV; Ravat SH; Jain N
BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35589273
[TBL] [Abstract][Full Text] [Related]
30. Oncogenic osteomalacia due to FGF23-expressing colon adenocarcinoma.
Leaf DE; Pereira RC; Bazari H; Jüppner H
J Clin Endocrinol Metab; 2013 Mar; 98(3):887-91. PubMed ID: 23393166
[TBL] [Abstract][Full Text] [Related]
31. Tumor-induced hypophosphatemic osteomalacia diagnosed by the combinatory procedures of magnetic resonance imaging and venous sampling for FGF23.
Nasu T; Kurisu S; Matsuno S; Tatsumi K; Kakimoto T; Kobayashi M; Nakano Y; Wakasaki H; Furuta H; Nishi M; Sasaki H; Suzuki H; Ito N; Fukumoto S; Nanjo K
Intern Med; 2008; 47(10):957-61. PubMed ID: 18480582
[TBL] [Abstract][Full Text] [Related]
32. The Game Is Afoot.
Yozamp N; Charles J; Shah H; Vaidya A; Pallais JC
N Engl J Med; 2020 May; 382(22):e78. PubMed ID: 32459927
[No Abstract] [Full Text] [Related]
33. Oncogenic osteomalacia: two case reports with surprisingly different outcomes.
Seijas R; Ares O; Sierra J; Pérez-Dominguez M
Arch Orthop Trauma Surg; 2009 Apr; 129(4):533-9. PubMed ID: 19125258
[TBL] [Abstract][Full Text] [Related]
34. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
Arai R; Onodera T; Terkawi MA; Mitsuhashi T; Kondo E; Iwasaki N
BMC Musculoskelet Disord; 2017 Feb; 18(1):79. PubMed ID: 28193220
[TBL] [Abstract][Full Text] [Related]
35. [Hypophosphatemic oncogenic osteomalacia].
Mátyus J; Szebenyi B; Rédl P; Mikita J; Gáspár L; Haris A; Radó J; Kakuk G
Orv Hetil; 2000 Dec; 141(51):2785-8. PubMed ID: 11196239
[TBL] [Abstract][Full Text] [Related]
36. [Chronic bone pain due to raised FGF23 production? The importance of determining phosphate levels].
de Jongh RT; Vervloet MG; Bravenboer N; Heijboer AC; den Heijer M; Lips P
Ned Tijdschr Geneeskd; 2013; 157(28):A5908. PubMed ID: 23841927
[TBL] [Abstract][Full Text] [Related]
37. [Tumor localization and treatment of tumor-induced osteomalacia].
Beil FT; Stürznickel J; Rolvien T; Amling M; Oheim R
Z Rheumatol; 2022 Apr; 81(3):182-188. PubMed ID: 35103802
[TBL] [Abstract][Full Text] [Related]
38. Autosomal dominant hypophosphatemic rickets/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder.
Econs MJ; McEnery PT
J Clin Endocrinol Metab; 1997 Feb; 82(2):674-81. PubMed ID: 9024275
[TBL] [Abstract][Full Text] [Related]
39. Tumor-induced osteomalacia: successful treatment by radio-guided tumor surgery.
Harbeck B; Schöcklmann H; Seekamp A; Czech N; Mönig H
J Clin Rheumatol; 2009 Feb; 15(1):31-4. PubMed ID: 19125132
[TBL] [Abstract][Full Text] [Related]
40. Severe hypophosphatemic osteomalacia with Fanconi syndrome, renal tubular acidosis, vitamin D deficiency and primary biliary cirrhosis.
Bando H; Hashimoto N; Hirota Y; Sakaguchi K; Hisa I; Inoue Y; Imanishi Y; Seino S; Kaji H
Intern Med; 2009; 48(5):353-8. PubMed ID: 19252361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
